Discontinued — last reported Q4 '22
Life Sciences Solutions — CapEx
Thermo Fisher Scientific Life Sciences Solutions — CapEx remained flat by 0.0% to $122.50M in Q4 2022 compared to the prior quarter. Year-over-year, this metric declined by 39.5%, from $202.50M to $122.50M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Higher spending typically signals investment in future growth and capacity expansion, whereas lower spending may indicate a focus on cash preservation or a mature asset base.
Detailed definition
This metric measures the cash outflows used by the segment to acquire, upgrade, and maintain physical assets such as pro...
Peer comparison
Most large-cap scientific instrument and reagent manufacturers report capital expenditures as a key indicator of their ongoing investment in manufacturing and R&D infrastructure.
tmo_segment_life_sciences_solutions_capital_expendituresHistorical Data
| FY'21 | FY'22 | |
|---|---|---|
| Value | $810.00M | $490.00M |
| YoY Change | — | -39.5% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's life sciences solutions — capex?
- Thermo Fisher Scientific (TMO) reported life sciences solutions — capex of $122.50M in Q4 2022.
- How has Thermo Fisher Scientific's life sciences solutions — capex changed year-over-year?
- Thermo Fisher Scientific's life sciences solutions — capex decreased by 39.5% year-over-year, from $202.50M to $122.50M.
- What does life sciences solutions — capex mean?
- The amount of money the segment spends on physical assets like machinery and facilities to support its operations.